We found an increase in brain-derived neurotrophic factor (BDNF) and growth factors in Foralumab treated patients that was not observed in untreated COVID-19 subjects or healthy controls (SI Appendix, Fig. S7A and Table S2 and Dataset S7). This evidence concerns the gene BDNF and COVID-19.